Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.59 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.54 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.54 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.54 |
| ▸ | DPP7 | Q9UHL4 | 7/20 | 0.50 |
| ▸ | DPP8 | Q6V1X1 | 3/20 | 0.50 |
| ▸ | DPP9 | Q86TI2 | 3/20 | 0.50 |
| ▸ | MMP2 | P08253 | 1/20 | 0.46 |
| ▸ | DPP4 | P27487 | 2/20 | 0.44 |
| ▸ | TERT | O14746 | 3/20 | 0.42 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.42 |
| ▸ | TLR2 | O60603 | 2/20 | 0.41 |
| ▸ | LTA4H | P09960 | 1/20 | 0.41 |
| ▸ | RRM1 | P23921 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6315105 | 1.00 | GSR (0.59) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL5499007 | 0.84 | GSR (0.61) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL5667567 | 0.83 | GSR (0.59) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL5495401 | 0.83 | GSR (0.59) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL198508 | 0.83 | GSR (0.59) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL5667565 | 0.83 | GSR (0.59) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL18373043 | 0.83 | GSR (0.59) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL11771047 | 0.83 | GSR (0.59) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL14470703 | 0.83 | DPP7 (0.40) | GSRGNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL9337297 | 0.81 | GSR (0.57) | GSRGNAI3GNAO1GNAI1DPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112538152-A | Waterborne polyurethane-polyurea dispersion and preparation method and application thereof | 万华化学集团股份有限公司 | 2021-03-23 | — | — | CN | claimed |
| US-4138292-A | ENZYMES OR MICROORGANISMS IN A SULFATED POLYSACCHARIDE GEL | TANABE SEIYAKU CO., LTD. (JP) | 1979-02-06 | — | — | US | claimed |
| US-20230285590-A1 | POLYMER-CARGO-COMPLEXES COMPRISING CROSS-LINKED COPOLYMERS AND CARGO MOLECULES | Helmholtz-Zentrum für Infektionsforschung GmbH (DE) | 2023-09-14 | — | — | US | disclosed |
| US-20230285590-A1 | POLYMER-CARGO-COMPLEXES COMPRISING CROSS-LINKED COPOLYMERS AND CARGO MOLECULES | Helmholtz-Zentrum für Infektionsforschung GmbH (DE) | 2023-09-14 | — | — | US | disclosed |
| CN-114702686-B | Polymer modified magnetic bead and application of qualitative and quantitative analysis of sub-metabolome thereof | 中国医学科学院基础医学研究所 | 2022-12-13 | — | — | CN | disclosed |
| CN-114702686-A | Polymer modified magnetic bead and application of qualitative and quantitative analysis of sub-metabolome thereof | 中国医学科学院基础医学研究所 | 2022-07-05 | — | — | CN | disclosed |
| WO-2021259783-A1 | POLYMER-CARGO-COMPLEXES COMPRISING CROSS-LINKED COPOLYMERS AND CARGO MOLECULES | Helmholtz-Zentrum für Infektionsforschung GmbH (DE) | 2021-12-30 | — | — | WO | disclosed |
| EP-3928798-A1 | POLYMER-CARGO-COMPLEXES COMPRISING CROSS-LINKED COPOLYMERS AND CARGO MOLECULES | Helmholtz-Zentrum für Infektionsforschung GmbH (DE) | 2021-12-29 | — | — | EP | disclosed |
| CN-112538152-A | Waterborne polyurethane-polyurea dispersion and preparation method and application thereof | 万华化学集团股份有限公司 | 2021-03-23 | — | — | CN | disclosed |
| EP-2976099-B1 | AMINOFUCOIDAN AS A VECTOR FOR FIBRINOLYSIS IN THROMBOTIC DISEASES | INST NAT SANTE RECH MED (FR) | 2018-08-01 | — | — | EP | disclosed |
| WO-2014147597-A1 | AMINOFUCOIDAN AS A VECTOR FOR FIBRINOLYSIS IN THROMBOTIC DISEASES | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) | 2014-09-25 | — | — | WO | disclosed |
| CN-1968718-B | Use of isocyanate functional composition in preparing adhesive for tissue adhesion | UNIV PITTSBURGH | 2010-06-09 | — | — | CN | disclosed |
| CN-1968718-A | Medical adhesive and methods of tissue adhesion | UNIV PITTSBURGH (US) | 2007-05-23 | — | — | CN | disclosed |
| US-6958325-B2 | Cationic polysaccharide compositions | EFRAT BIOPOLYMERS LIMITED (IL) | 2005-10-25 | — | — | US | disclosed |
| US-20020146826-A1 | Biodegradabel polysaccharide derivative for use in human therapeutic and diagnostics | POLYGENE LTD. | 2002-10-10 | — | — | US | disclosed |
| EP-1222926-A1 | Cationic polysaccharide compositions | Polygene Ltd. (IL) | 2002-07-17 | — | — | EP | disclosed |
| US-5759827-A | Acylated oligopeptides for transfecting cells | HOFFMANN-LA ROCHE INC. (US) | 1998-06-02 | — | — | US | disclosed |
| EP-0368273-A2 | New method of assay for antigen | Ishikawa, Eiji (JP) | 1990-05-16 | — | — | EP | disclosed |
| US-4138292-A | ENZYMES OR MICROORGANISMS IN A SULFATED POLYSACCHARIDE GEL | TANABE SEIYAKU CO., LTD. (JP) | 1979-02-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230285590-A1 | POLYMER-CARGO-COMPLEXES COMPRISING CROSS-LINKED COPOLYMERS AND CARGO MOLECULES | KPNA6, EEA1, RAB5IF | GSR 4735/4885GNAI3 1203/4885GNAO1 3424/4885 |
| US-20020146826-A1 | Biodegradabel polysaccharide derivative for use in human therapeutic and diagnostics | ALG1, CD44, CHIT1 | GSR 3609/4885GNAI3 4865/4885GNAO1 4716/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.